Once-daily Clarium (clarithromycin) to be available in Korea

Published: 2006-12-08 06:57:00

Updated: 2006-12-08 06:57:00

There is good news for people with certain respiratory infections who require antibiotics but don't like the inconvenience of multiple daily dosing.

Sam-A Pharm said it has recently signed a licensing agreement with Belgium-based Laboratoires SMB to develop and market Clarium 200-330 mg in Kor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK